Sandoz Defeat On Amgen’s Otezla Pushes US Generic Opportunity Back To 2028

Zydus Cadila Also On Receiving End Of Unfavorable Ruling

 
• By Dean Rudge
  
Amgen
The court's opinion is currently under seal • Source: Alamy

More from Generics

More from Products